Michael J. Fox Foundation grants

Expire le 22 octobre 2020

The Michael J. Fox Foundation works tirelessly to accelerate promising research toward breakthroughs for people with Parkinson’s.

Our funding programs support basic, translational and clinical research from academia and industry. In addition to funding, awardees benefit from working with our internal research staff and broad network of scientific and industry advisors.

Accelerating Publication of Parkinson’s Disease Replication Data


To address the bias toward the publication of novel positive results, The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and the Journal of Parkinson’s Disease (JPD) invite researchers to “open their notebooks” and submit unpublished results from experiments that attempted to replicate previously published findings from other laboratories.

Analysis of Patient-Reported Outcomes from Fox Insight

Objective: This Request for Applications (RFA) seeks to fund analyses of the patient-reported outcomes (PROs) and genetic data collected through the Fox Insight study.

Development and Validation of Improved Outcome Measures

Objective: The Michael J. Fox Foundation (MJFF) seeks applications to develop objective biomarkers that can support therapeutic development in Parkinson’s.

PIPETTE: 4R Tau and Alpha-Synuclein PET Tracer Development

Objective: The PIPETTE Consortium (Philanthropic Investments in PET TracErs) is a funding partnership formed in 2017 by The Michael J. Fox Foundation and Rainwater Charitable Foundation (conveners of the Tau Consortium).

Target Advancement Program

Objective: The Michael J. Fox Foundation seeks applications that leverage and translate basic research to enable therapeutic development.

Therapeutic Pipeline Program


The Michael J. Fox Foundation seeks applications with potential for fundamentally altering disease course and/or significantly improving treatment of symptoms above and beyond current standards of care.

Application and details